Filter by:
Category
Category
- All categories
- Advances for Medical Professionals
- Medical News for Patients & Visitors
- NYP News
- Outcomes & Quality Reports
Specialty
Specialty
- All specialties
Type
Type
- All types
- Clinical innovations
- Newsletter
- Research
Years
Years
- All years
Locations
Locations
- All locations
Filtered by:
-
NYP News Close NYP News filter
- Clear All
NewYork-Presbyterian Komansky Children’s Hospital Raises 2-5 Million at 13th Plates For Pediatrics
NewYork-Presbyterian Komansky Children’s Hospital of Children’s Hospital of New York raised $2.5 million at the 13th Plates for Pediatrics benefit. A collaboration with luxury retailer Saks Fifth Avenue, the benefit drew more than 400 attendees to Cipriani South Street at Casa Cipriani on Tuesday, February 25.
Mapping of Specialized Blood Vessel Cells May Lead to Diabetes Treatments
The distinct population of endothelial cells that line blood vessels in the insulin-producing “islets” of the human pancreas have been notoriously difficult to study, but Weill Cornell Medicine investigators have now succeeded in comprehensively detailing the unique characteristics of these cells.
Sesame Workshop and NYP Announce Partnership to Promote Children’s Health and Advance Health Equity
The two organizations will partner to foster healthy habits in young children and their families by offering free resources and videos and “Sesamatized” spaces.
NYP Partners with Van Leeuwen to Increase Blood Donations in NY With a Sweet Offer
NewYork-Presbyterian, one of the nation’s leading healthcare systems, is partnering with Van Leeuwen Ice Cream to increase blood donations in New York City by making the experience of donating blood a little sweeter.
NYP Westchester Opens Newly Renovated Labor and Delivery Unit
The new unit provides exceptional, personalized care from Columbia physicians for pregnant women and their newborns in Westchester County.
NYP Opens Och Spine at NewYork-Presbyterian The Spiral
New ambulatory care center expands access to world-class spine care from Columbia and Weill Cornell Medicine and provides a seamless patient experience
Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial
Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.
Study Details Surprising Biological Mechanisms Underlying Severe COVID19
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine, Johns Hopkins Medicine, Children’s Hospital of Philadelphia, and the University of Pittsburgh in collaboration with other institutions.
Page1 of 164